2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Motilal Oswal Mutual Fund`s Guru Purnima Film ?The C...
Indo US Bio-Tech jumps on inking MoU with ICAR-IARI
Effortless Elegance: The Timeless Appeal of the Slip...
Cambodia records 7,000 dengue fever cases with 15 de...
Ruiz brace sends PSG into Club World Cup final
India A men`s hockey team secures second win on Euro...
Guru Purnima: Priti Adani urges to honour teachers b...
World-famous Shravani Mela begins in Deoghar, lakhs ...
Maharashtra CM Devendra Fadnavis inaugurates `Sindoo...
Uttar Pradesh CM Yogi Adityanath holds Janta Darsha...
